Patient Demographics

Obesity: A National Epidemic

Obesity rates have increased drastically in the last 25 years, and have now become a national public health concern.1 It is estimated that:

  • Over 72 million people were obese in 2005 to 20061
  • 15 million individuals meet the criteria for morbid obesity (BMI > 40 or BMI > 35 with comorbidity)2
  • 26.4 million Americans have a BMI of 30-35 kg/m2 with at least one comorbid condition3
  • Patients with a BMI > 40 lose about 10 years off their expected lifespan — similar to the effect of lifelong smoking4
  • A 20 year-old man with a BMI of 45 is expected to lose 13 years of life compared to a normal-weight individual5
  • Bariatric surgery is discussed with only 25% of morbidly obese patients6
  • By 2030, the heath care costs associated with overweight and obese patients could account for 16% to 18% of total US health care costs7

Obesity in the United States

Given these staggering statistics and the fact that bariatric surgery is the only proven intervention for sustained weight loss in severely obese patients8, it is important that physicians seriously consider bariatric surgery when treating severely obese patients.

Use the resources available in the Document Library - Origination section for information on how to introduce bariatric procedure to your patients.

Identifying LAP-BAND AP® Adjustable Gastric Banding System Patient Candidates

The LAP-BAND AP® System is indicated for use in patients who:

  • Are at least 30 pounds overweight with a BMI ≥ 30kg/m2 with one or more obesity related comorbid conditions
  • Have a BMI ≥ 40 kg/m2
  • Have failed non-surgical weight loss strategies (diet, pharmaceutical therapy, behavior modification, exercise)
  • Are willing to adhere to post-operative care and follow-up

References:

  1. Ogden et al. Obesity Among Adults in the United States, NCHS Data Brief, 2007
  2. ASMBS Web site. Metabolic & bariatric surgery fact sheet. Available at www.asbs.org/Newsite07/media/asmbs_fs_surgery.pdf. Accessed August 29, 2009
  3. 2009 CDC Behavioral Risk Factor Surveillance System (BRFSS) annual data.
  4. Whitlock G, Lewington S, Sherliker P et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. The Lancet. 2009; 373: 1083-1096
  5. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187-193.
  6. Data on file, Allergan, Inc. Referring Physicians Market Research. 2008.
  7. Zagorsky, J. L. Health and wealth: the late-20th century obesity epidemic in the U.S, Economics and Human biology, 2005
  8. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database of Systematic Reviews 2008, Issue 4.

Featured Item

2011 Patient Seminar Deck - PC Version

2011 Patient Seminar Deck - PC Version

 
Privacy Policy | About Us | Contact Us | Sitemap | Risk Information
© 2011 Allergan, Inc., Irvine CA 92612, U.S.A. ® Mark Owned by Allergan, Inc. All rights reserved. FITDAY is a registered service mark of Internet Brands, Inc. CareCredit is a registered trademark of CareCredit LLC, General Electric Co, or their subsidiaries. Emmi is a registered trademark owned by Emmi Solutions, LLC. Realize™ is a trademark of Ethicon Endo-Surgery. YouTube is trademark owned by YouTube, LLC.  APC74CS10.
This site is intended for US residents only.